Bortezomib and vorinostat in combination with mitoxantrone, dexamethasone, and pegasparaginase during induction and reinduction for infants with acute lymphoblastic leukaemia: a multicentre single-arm phase 1/2 study Article

sustainable development goals

publication date

  • March 1, 2026

webpage

published in

start page

  • e144

end page

  • e156

volume

  • 13

issue

  • 3